Leukocyte adhesion deficiency type II
- PMID: 10571012
- DOI: 10.1016/s0925-4439(99)00071-x
Leukocyte adhesion deficiency type II
Abstract
Leukocyte adhesion deficiency type II (LAD II) is a rare disorder characterized by recurrent infections, persistent leukocytosis, and severe mental and growth retardation. LAD II neutrophils are deficient in expression of selectin ligand activity, and exhibit a correspondingly diminished ability to roll on endothelium and to traffic to inflammatory sites in vivo. LAD II patients exhibit a deficiency in the expression of cell surface fucosylated glycan structures that include the H and Lewis blood group determinants and the sialyl Lewis x epitope, yet the corresponding fucosyltransferase activities responsible for synthesis of these structures are expressed at normal levels. The molecular defect in LAD II has been localized to the pathway that synthesizes GDP-fucose from GDP-mannose. However, the two known component enzymes in this GDP-fucose biosynthetic pathway are normal in sequence and in expression levels in LAD II cells. The genetic lesion in LAD II that accounts for the generalized fucosylation defect in LAD II patients remains to be determined.
Similar articles
-
Leukocyte Adhesion Deficiency Type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium.J Clin Invest. 1998 Jun 1;101(11):2438-45. doi: 10.1172/JCI905. J Clin Invest. 1998. PMID: 9616215 Free PMC article.
-
Defective intracellular activity of GDP-D-mannose-4,6-dehydratase in leukocyte adhesion deficiency type II syndrome.FEBS Lett. 1998 Jun 16;429(3):274-8. doi: 10.1016/s0014-5793(98)00615-2. FEBS Lett. 1998. PMID: 9662431
-
Decreased availability of GDP-L-fucose in a patient with LAD II with normal GDP-D-mannose dehydratase and FX protein activities.J Leukoc Biol. 1999 Jul;66(1):95-8. doi: 10.1002/jlb.66.1.95. J Leukoc Biol. 1999. PMID: 10410995
-
Leukocyte adhesion deficiency II-from A to almost Z.Immunol Rev. 2000 Dec;178:138-47. doi: 10.1034/j.1600-065x.2000.17805.x. Immunol Rev. 2000. PMID: 11213799 Review.
-
Leukocyte adhesion deficiency II: therapy and genetic defect.Cells Tissues Organs. 2002;172(3):161-73. doi: 10.1159/000066968. Cells Tissues Organs. 2002. PMID: 12476046 Review.
Cited by
-
Neural and synaptic defects in slytherin, a zebrafish model for human congenital disorders of glycosylation.PLoS One. 2010 Oct 29;5(10):e13743. doi: 10.1371/journal.pone.0013743. PLoS One. 2010. PMID: 21060795 Free PMC article.
-
Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.J Clin Invest. 2002 Jul;110(1):127-36. doi: 10.1172/JCI14996. J Clin Invest. 2002. PMID: 12093896 Free PMC article.
-
Changes in the invasive and metastatic capacities of HT-29/M3 cells induced by the expression of fucosyltransferase 1.Cancer Sci. 2007 Jul;98(7):1000-5. doi: 10.1111/j.1349-7006.2007.00484.x. Epub 2007 Apr 23. Cancer Sci. 2007. PMID: 17459061 Free PMC article.
-
Structure-function relationships of human milk oligosaccharides.Adv Nutr. 2012 May 1;3(3):383S-91S. doi: 10.3945/an.111.001404. Adv Nutr. 2012. PMID: 22585916 Free PMC article. Review.
-
Pathways and bottlenecks in the web of inflammatory adhesion molecules and chemoattractants.Immunol Res. 2001;24(1):87-95. doi: 10.1385/IR:24:1:87. Immunol Res. 2001. PMID: 11485212 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
